Carbendazim

DB13009InvestigationalSmall molecule

Carbendazim has been used in trials studying the treatment of Lymphoma and Unspecified Adult Solid Tumor, Protocol Specific.

Chemical structure of Carbendazim
Mechanism
Curator reviewed
Formula / weight
C9H9N3O2 · 191.1867 g/mol (avg)
Code names
A 118 · BAS-67054F · EK-578 · FB-642 · NSC-109874

Resolves to

Compound
UNIIH75J14AA89CAS10605-21-7ChEMBLCHEMBL70971ChEBI3392PubChem25429KEGGC10897
Structure
InChIKeyTWFZGCMQGLPBSX-UHFFFAOYSA-NSMILESCOC(=O)NC1=NC2=CC=CC=C2N1
Targets
P35869AHR

What you can answer from here — as of May 06, 2022

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Carbendazim, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In